Latvia - Latvian Association for Crohn´s and Colitis - LKKSB
Published contents
Our colleagues from the Ukrainian IBD patient association ¨Fulfilling Life" have prepared this important survey on the current situation of IBD patients affected by the war in Ukraine.
The survey gives an overview of the immediate effects, medical care during the war as well as other...
Our latest issue of the EFCCA Magazine is out! You will find information about our latest activities, news from our members and other exciting articles related to IBD and the patient community.
Enjoy the read!
The YELLOWSTONE Program is a series of Phase 3 clinical studies for people with moderately to severely active Crohn’s disease. These studies will evaluate the safety and effectiveness of an oral investigational study drug (ozanimod) which is taken once daily. Ozanimod is not a biologic,...
Interesting article published by the European Medicine Agency looking into the added value of Patient Engagement.
https://www.frontiersin.org/articles/10.3389/fmed.2021.811855/full
Purple Talk Watch our Patient Testimonials
This year, for World IBD Day 2022, EFCCA would like to raise awareness about the impact IBD has on elderly people. Under the slogan ...
We have launched our Youth Academy with the aim to increase the representativeness of the youth group, create a cohesive group of leaders of tomorrow and to empower young representatives.
The first training module was released last 29 November 2021 via the EFCCA online learning platform...
FATIGUE IN IBD
Fatigue is an important underecognized clinical problem in patients with IBD and one of the most frequently reported concerns of patients. It affects nearly 50 % of patients in clinical remission and 80% of those with active disease, resulting in a decrease...
The results of the survey " Patients’ perceptions of surgery for inflammatory bowel disease" have been published this month (16 July) in the Colorectal Disease Journal.
EFCCA has collaborated in this study which was led by Professor Antonino Spinelli (Humanitas Clinical and Research...